Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Martin T King, M.D.

Concepts (123)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy16202112924.730 Why?
Prostatic Neoplasms252021104392.270 Why?
Androgen Antagonists9202112701.440 Why?
Prostate-Specific Antigen10202122111.400 Why?
Prostatectomy7202018110.860 Why?
Radiotherapy, Intensity-Modulated320217670.680 Why?
Ear Neoplasms120161160.610 Why?
Rhabdomyosarcoma, Embryonal12016940.610 Why?
Ear Canal120161430.600 Why?
Four-Dimensional Computed Tomography220171270.580 Why?
Antineoplastic Agents, Hormonal2202115420.550 Why?
Radiotherapy Dosage5201929910.490 Why?
Neoplasm Metastasis2202153910.460 Why?
Antibodies, Monoclonal, Murine-Derived120157410.450 Why?
Watchful Waiting420194520.420 Why?
Respiration1201516850.360 Why?
Radiotherapy Planning, Computer-Assisted1201614780.340 Why?
Hodgkin Disease1201514280.330 Why?
Radiosurgery3202112710.330 Why?
SEER Program4202015700.320 Why?
Magnetic Resonance Spectroscopy1201636860.290 Why?
Radiotherapy, Adjuvant3202118850.280 Why?
Retrospective Studies152021673200.280 Why?
Combined Modality Therapy6202091140.260 Why?
Antineoplastic Agents32018138980.260 Why?
Aged2320211622710.240 Why?
Databases, Factual7201978650.240 Why?
Belgium120211010.230 Why?
Survival Rate42020136060.210 Why?
Male2720213524650.200 Why?
Lung2201791820.200 Why?
Risk Assessment42020237390.200 Why?
Alphapapillomavirus120211700.190 Why?
Propensity Score3202117510.170 Why?
Cyclin-Dependent Kinase Inhibitor p16120217440.170 Why?
Cervix Uteri120215640.160 Why?
Proportional Hazards Models42020125250.160 Why?
Middle Aged1920212164680.160 Why?
Humans3120216866630.160 Why?
Urethral Stricture12016570.160 Why?
Prognosis62020289230.160 Why?
Disease-Free Survival3201771950.160 Why?
Neoplasm Staging62021112650.140 Why?
Follow-Up Studies62020397370.140 Why?
Lung Neoplasms22017120090.140 Why?
Radiation Pneumonitis12015980.140 Why?
Magnetic Resonance Imaging22018331860.140 Why?
Organs at Risk120163250.140 Why?
Morbidity1201916740.130 Why?
Neoplasms, Second Primary120219620.130 Why?
Urethra120164100.130 Why?
Antineoplastic Combined Chemotherapy Protocols12015111150.130 Why?
Tidal Volume120154970.120 Why?
Radiotherapy, Conformal120165630.120 Why?
Chemotherapy, Adjuvant2202134860.120 Why?
Consensus1202124340.120 Why?
Travel120187400.120 Why?
Time Factors32021422710.120 Why?
Sample Size120157660.120 Why?
Treatment Outcome52019609910.120 Why?
Endometrial Neoplasms1202112850.120 Why?
Neoplasm Recurrence, Local2202186100.110 Why?
Rectum120169050.110 Why?
Radiometry120168180.110 Why?
Cochlea120167550.100 Why?
Kinetics1201969790.100 Why?
Prostate1201714320.100 Why?
Papillomavirus Infections1202113710.100 Why?
Salvage Therapy1201713110.100 Why?
Survival Analysis32018107660.100 Why?
Patient Compliance1202027630.100 Why?
Uterine Cervical Neoplasms1202119110.090 Why?
Statistics, Nonparametric1201530090.090 Why?
Radiation Injuries1201612740.090 Why?
Cohort Studies52021387320.080 Why?
Boston1202195340.080 Why?
Early Detection of Cancer1202126560.080 Why?
African Americans2202051440.080 Why?
Regression Analysis1201566690.070 Why?
Health Services Accessibility2202049280.070 Why?
Cell Transformation, Neoplastic1201530530.070 Why?
Randomized Controlled Trials as Topic1202193370.070 Why?
Recurrence1201581980.060 Why?
Prospective Studies32021490710.060 Why?
Aged, 80 and over62020593310.060 Why?
Logistic Models42019138070.060 Why?
Odds Ratio32020101080.060 Why?
Risk Factors22019692780.060 Why?
Quality of Life12021106760.050 Why?
Pulmonary Disease, Chronic Obstructive1201528420.050 Why?
Colposcopy120211360.050 Why?
Selection Bias120203480.050 Why?
United States32019655790.040 Why?
National Cancer Institute (U.S.)120172450.040 Why?
Cryotherapy120171680.040 Why?
Kaplan-Meier Estimate2201769700.040 Why?
Comparative Effectiveness Research120206830.040 Why?
Infant12016339180.030 Why?
Confidence Intervals1202030570.030 Why?
Cancer Care Facilities120174150.030 Why?
Triage120219320.030 Why?
HeLa Cells1202133950.030 Why?
Community Health Centers120174330.030 Why?
Enzyme-Linked Immunosorbent Assay1202140760.030 Why?
Adult520212114000.030 Why?
Female520213754590.030 Why?
Tomography, X-Ray Computed12016204090.030 Why?
Child, Preschool12015411590.030 Why?
Forced Expiratory Volume1201717390.030 Why?
Feasibility Studies1202148070.030 Why?
Geriatric Assessment1201712540.020 Why?
Radiotherapy1201716740.020 Why?
Young Adult12015560520.020 Why?
Referral and Consultation1202132960.020 Why?
Child12015713610.020 Why?
Disease Management1201925860.020 Why?
Adolescent12015849570.020 Why?
Academic Medical Centers1201727770.020 Why?
Sensitivity and Specificity12021150750.020 Why?
Risk1201799150.020 Why?
Multivariate Analysis12017127340.020 Why?
Disease Progression12017132040.010 Why?
Age Factors12017192950.010 Why?
King's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (123)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.